Among them, several tsRNAs (ts-55, ts-60, and tRFdb-3003a/b) were remarkably down-regulated in gliomas, the expressions of tRFdb-3003a and tRFdb-3003b were associated with survival outcome and IDH-mutants status of glioma patients. The gene discussed is IDH1; the disease is central nervous system cancer.